The Role of Diet and Lifestyle in Breast Cancer Survival
NCT00701584 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3390
Last updated 2014-05-20
Summary
Diet has been found to influence hormone production and metabolism which in turn could affect the incidence of hormone related cancers. Consumption of soy-containing foods, known to be rich in phytoestrogens, is thought to be one of the chemoprotective factors against breast cancer in Asian populations. Phytoestrogens have a wide range of metabolic effects and may have a role in effecting breast cancer risk. Although there is mounting evidence of the positive influence of phytoestrogens on breast cancer risk, very little research has been carried out in humans as to the effects of phytoestrogens on breast cancer recurrence and survival. The DietCompLyf study aims to explore this effect by carrying out an observational study in 3,000 breast cancer women in the UK. The effects of diet, lifestyle practices and use of complementary treatments will also be investigated. Participants are recruited 9-15 months post-diagnosis and followed up for 5 years. Questionnaires as well as blood and urine samples are collected annually.
Conditions
Sponsors & Collaborators
-
United Kingdom Clinical Research Collaboration
collaborator OTHER -
University College London Hospitals
lead OTHER
Principal Investigators
-
Miriam V Dwek, PhD · University of Westminster
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2010-08-31
- Completion
- 2014-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer
NCT02161315 ·Status: UNKNOWN
-
Diet and Estrogen Metabolism in Postmenopausal Women
NCT00003098 ·Status: COMPLETED ·Phase: NA
-
Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors
NCT06214598 ·Status: RECRUITING ·Phase: NA
-
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
NCT04268134 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
NCT00031850 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors
NCT05628077 ·Status: UNKNOWN
-
Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
NCT00723398 ·Status: COMPLETED ·Phase: NA
-
Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
NCT00612560 ·Status: COMPLETED ·Phase: NA
-
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer
NCT03210441 ·Status: UNKNOWN
-
Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer
NCT00006030 ·Status: UNKNOWN ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 ·Status: COMPLETED ·Phase: PHASE2
-
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
NCT00078832 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
NCT01144572 ·Status: COMPLETED
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
NCT00673335 ·Status: COMPLETED ·Phase: PHASE3
-
Testosterone Implants and the Incidence of Breast Cancer
NCT03768258 ·Status: COMPLETED
-
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients
NCT02132000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer
NCT04023292 ·Status: UNKNOWN ·Phase: PHASE2
-
The Malaysian Soy and Mammographic Density Study
NCT03686098 ·Status: UNKNOWN ·Phase: NA
-
Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
NCT06781762 ·Status: RECRUITING
-
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710 ·Status: UNKNOWN
-
Evaluation of Sexual Quality of Life for Breast Cancer
NCT04200001 ·Status: COMPLETED
-
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
NCT03931928 ·Status: COMPLETED ·Phase: PHASE2